Crossmark

The era of prostate-specific membrane antigen (PSMA)–based theranostics for hepatocellular carcinoma is upcoming: are we ready for it?

Published Online: 2022-08-10

Published Print: 2022-10

Authors

Filippi, Luca https://orcid.org/0000-0003-4423-5496
Braat, Arthur J.

Schillaci, Orazio
License Information

Text and Data Mining valid from 2022-08-10

Version of Record valid from 2022-08-10
More Information

Article History

Received: 9 July 2022

Accepted: 4 August 2022

First Online: 10 August 2022

Declarations

:

: All procedures were performed in accordance with the ethical standards of the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

: The authors declare no competing interests.

Document is current